Further, the specificities of the [18F]F-fluorobenzyl-azide-Heraptamer1 and [18F]F-fluorobenzyl-azide-Heraptamer2 were demonstrated by the low tumour uptake ratios in HER2-negative MDA-MB-231 tumour [123]. The gene discussed is ERBB2; the disease is neoplasm.